Stay updated on IntelliPharmaCeutics International Press Releases
Sign up to get notified when there's something new on the IntelliPharmaCeutics International Press Releases page.

Latest updates to the IntelliPharmaCeutics International Press Releases page
- Check7 days agoChange DetectedExpanded related stories and author highlights now appear in the sidebar, increasing navigational content while leaving the main article text unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference4%

- Check14 days agoChange DetectedA Job Trends sidebar with related article links was added, and several older article blocks were removed.SummaryDifference4%

- Check21 days agoChange DetectedNew sidebar items introduce additional biotech news stories such as IPO coverage and market updates. Some genetics-focused topics previously present in the sidebar, like Gene editing, were removed from the listings.SummaryDifference4%

- Check28 days agoChange DetectedIntellipharmaceutics announces its listing transfer to NEX and delisting from the TSX with the trading symbol IPCI.H, while continuing to trade on OTCQB. The company also announces a new rolling stock option plan that is subject to shareholder approval.SummaryDifference4%

- Check35 days agoChange DetectedNew related-story headlines were added to the page sidebar, including topics like Obesity, JPM26 stories, vaccines, and CAR-T. Several existing headlines were removed or updated.SummaryDifference4%

- Check42 days agoChange DetectedThe page's related stories/sidebar items were updated, adding several biotechnology headlines (including obesity-related pieces and JPM26 coverage) and removing older items. The core press release content remains unchanged.SummaryDifference4%

Stay in the know with updates to IntelliPharmaCeutics International Press Releases
Enter your email address, and we'll notify you when there's something new on the IntelliPharmaCeutics International Press Releases page.